"Designing Growth Strategies is in our DNA"

Europe Insulin Pump Market Size, Share & COVID-19 Impact Analysis, By Product Type (Pumps [Tethered Pumps, Patch Pumps, and Others] and Consumables), By Disease Indication (Type 1 Diabetes and Type 2 Diabetes), By Distribution Channel (Hospital Pharmacy and Retail & Online Pharmacy), and Regional Forecast, 2023-2030

Region : Europe | Format: PDF | Report ID: FBI107536



Play Audio Listen to Audio Version

Europe is the second largest region in the global insulin pump market. The Europe insulin pump market size is projected to record a CAGR of 16.5% during the forecast period. The global insulin pump market is projected to grow from USD 4.60 billion in 2022 to USD 15.51 billion by 2030.

The rising incidence of type 1 diabetes among adults in Europe has increased the need for insulin and its delivery devices, such as insulin pumps, among the diabetic population. As per the International Diabetes Federation (IDF) Atlas factsheet in 2021, about 295,000 children and adolescents were suffering from type 1 diabetes in Europe.

This report on the Europe insulin pump market covers the following countries/regions – U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe.


Extensive Presence of Insulin Pump Manufacturers to Offer New Market Growth Opportunities

The need for insulin delivery devices, such as insulin pumps, is high owing to the rising prevalence of type 1 diabetes among adolescents in Europe. Also, the vast presence of insulin pump manufacturers enhanced the adoption of insulin therapy in the region, which will drive the market growth. Moreover, extensive presence of distribution channels for the supply of these pumps by major regional players is expected to fuel the market growth.

  • In September 2020, Insulet Corporation announced that it had received the extensive approval for its Omnipod DASH Insulin Management System across Europe, primarily in the U.K., Italy, Sweden, Finland, Norway, and Denmark.


Rising Number of Joint Ventures and Start-ups to Propel Product Demand

The demand for insulin and insulin pumps is increasing due to the rising need for diabetes care and management among the patient population. Thus, several market players are emphasizing on implementing various strategic initiatives, such as collaborations and acquisitions to develop technologically advanced products. Such initiatives will propel the introduction of and demand for new pumps, further fostering solid opportunities for the market’s growth during the forecast period.

  • In April 2022, Abbott, CamDiab, and Ypsomed announced that they were teaming up to develop and commercialize an integrated Automated Insulin Delivery (AID) system to help lessen the burden of round-the-clock diabetes management for people living with the disease. The initial focus of the partnership was expected to be on European countries.


Request a Free sample to learn more about this report.

High Proportion of Undiagnosed Diabetes Population to Decrease Adoption of Insulin Pumps

A large proportion of the European population remains undiagnosed for diabetes due to the long detection period and lack of symptoms among patients, especially those suffering from Type 2 diabetes. Moreover, lack of awareness about the disease among the general population and healthcare providers, and limited government screening programs have also increased the percentage of unidentified diabetes patients. Thus, vast presence of the undiagnosed population is limiting the demand for and adoption of diabetes care systems, such as insulin pumps in Europe, further hampering the market growth.

  • As per the International Diabetes Federation (IDF) estimates, in 2021, 35.7% (21.9 million) of the Europe population remained undiagnosed with diabetes.


The Europe market comprises dominant players such as Medtronic and Insulet Corporation. The dominance was due to their robust product offerings, high adoption, and strong regional distribution network, which are contributing to the market's growth.

  • In April 2021, Medtronic launched its extended infusion set in selected European countries, such as Finland and Belgium, which can be used for a period of up to seven days. The infusion set was developed in partnership with ConvaTec's Unomedical subsidiary, Convatec Infusion Care.

Other prominent players, such as Terumo Corporation and CeQur Simplicity, are also leading the market due to rising R&D investments and strategic collaborations & partnerships among the players to increase the Europe insulin pump market share.


  • Medtronic (Ireland)

  • Tandem Diabetes Care, Inc. (U.S.)

  • Insulet Corporation (U.S.)

  • ViCentra B.V. (Netherlands)

  • F. Hoffmann-La Roche Ltd (Switzerland)

  • Terumo Corporation (Japan)

  • CeQur Simplicity (Switzerland)

  • Microtec Medical Ltd (U.K.)


  • December 2022: Tandem Diabetes Care, Inc. announced a collaboration with AMF Medical SA, a Swiss company, to double its diabetes technology offerings of insulin pumps instantly.

  • March 2022: Terumo Corporation and Glooko, Inc., a global leader in data management, announced a technology-based partnership to deliver new diabetes data-sharing solutions globally. This new integration enabled people with diabetes to transfer recorded data from MEDISAFE WITH insulin patch pump to the Glooko platform.


To gain extensive insights into the market, Request for Customization

The report provides a detailed market analysis. It focuses on key aspects, such as the launch of new products, technological advancements, and the prevalence of diabetes. Besides this, the report offers important insights into the recent market trends and highlights key industry developments such as mergers, partnerships, and acquisitions, and the effect of COVID-19 on the market. In addition to the above-mentioned factors, the report encompasses several factors that have contributed to the market growth in recent years.

Report Scope & Segmentation



Study Period


Base Year


Estimated Year


Forecast Period


Historical Period


Growth Rate

CAGR of 16.5% from 2023 to 2030


Value (USD billion)


Type; Diabetes Type; Distribution Channel; and Country/Sub-Region

By Type

  • Pumps

    • Tethered

    • Patch

    • Others

  • Consumables

By Diabetes Type

  • Diabetes 1

  • Diabetes 2

By Distribution Channel

  • Hospital Pharmacies

  • Retail & Online Pharmacies


By Country/Sub-Region

  • U.K. (By Diabetes Type)

  • Germany (By Diabetes Type)

  • France (By Diabetes Type)

  • Italy (By Diabetes Type)

  • Spain (By Diabetes Type)

  • Scandinavia (By Diabetes Type)

  • Rest of Europe (By Diabetes Type)

Frequently Asked Questions

Recording a CAGR of 16.5%, the market will exhibit steady growth in the forecast period of 2023-2030.

Rising incidence of diabetes and increasing demand for these pumps among the regional population are some the key factors driving the market.

Medtronic and Tandem Diabetes Care, Inc. are the major players in the Europe market.

Germany dominated the market in 2022.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • May, 2023
  • 2022
  • 2019-2021
  • 90


  • $3850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.